North America Continuous Glucose Monitoring Market

North America Continuous Glucose Monitoring Market size was valued at USD 8.9 billion in 2025 and is forecast to grow from USD 10.0 billion in 2026 to reach USD 18.5 Billion by 2031, at a CAGR of 15.8%.

Description

The North America Continuous Glucose Monitoring Market size was valued at USD 8.9 billion in 2025 and is forecast to grow from USD 10.0 billion in 2026 to reach USD 18.5 Billion by 2031, at a CAGR of 15.8%. Continuous glucose monitoring systems use subcutaneous sensors, transmitters, and durable receiver components to provide real-time interstitial glucose readings, enabling patients and clinicians to track glucose trends continuously rather than relying on episodic finger-stick testing. The market sits at the intersection of digital health, diabetes management, and wearable-sensor technology, making it one of the most closely watched enabling technologies across the regional chronic-disease-management value chain.

Demand for continuous glucose monitoring platforms remains anchored by the structural shift from episodic testing to continuous, real-time data feeding automated insulin delivery and remote-care programs, rising Type 2 diabetes prevalence, and expanding payer coverage across the United States, Canada, and Mexico. Beyond insulin-dependent diabetes management, continuous glucose monitoring continues to enable applications in gestational diabetes tracking, non-insulin-using adult metabolic monitoring, and consumer wellness use cases as devices broaden into preventive health. Rising healthcare expenditure, expanding over-the-counter approval pathways, and continued sensor-price erosion are sustaining consumption even as the region transitions toward more connected, closed-loop insulin-delivery systems.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • North America Continuous Glucose Monitoring Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product (Sensors, Transmitters, Durable Components, Others)

      2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Others)

      3. By End User (Home Care Settings, Hospitals & Clinics, Diagnostic Centers, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • United States Continuous Glucose Monitoring Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Canada Continuous Glucose Monitoring Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Mexico Continuous Glucose Monitoring Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • North America Continuous Glucose Monitoring Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Abbott Laboratories

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. DexCom, Inc.

    3. Medtronic plc

    4. Ascensia Diabetes Care Holdings AG

    5. F. Hoffmann-La Roche Ltd

    6. Senseonics Holdings, Inc.

    7. Insulet Corporation

    8. Tandem Diabetes Care, Inc.

    9. GlucoTrack, Inc.

    10. Nemaura Medical Inc.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology